Process Engineer, Manufacturing Science & Technology (MSAT) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cabaletta Bio · 2 weeks ago

Process Engineer, Manufacturing Science & Technology (MSAT)

Cabaletta Bio is a clinical-stage biotechnology company focused on developing curative targeted cell therapies for autoimmune diseases. They are seeking a Process Engineer in their MSAT organization to drive technical rigor for scalable manufacturing, supporting technology transfer, process optimization, and ensuring compliance for late-stage development.

BiotechnologyHealth CareMedicalRoboticsTherapeutics

Responsibilities

Support technology transfer of mature, optimized processes to CMOs for clinical and late-phase cGMP manufacturing, ensuring readiness for PPQ and commercial-scale operations
Provide manufacturing oversight at CMOs, including person-in-plant support, review of manufacturing performance, and real-time issue escalation to maintain phase-appropriate control strategies
Execute process development and characterization studies, generate high-quality protocols and reports, and present data to cross-functional teams to inform PPQ planning and BLA Module 3 content
Ensure timely and accurate data capture, supporting data integrity requirements for late-stage filings, validation packages, and regulatory inspections
Maintain all training requirements in a compliant state, aligning with expectations for late-stage manufacturing and inspection readiness
Support phase-appropriate cell therapy processes using QbD principles, including identification of CPPs/CMAs and contributing to control strategy refinement for BLA submission
Identify and evaluate new technologies that enhance scalability, robustness, cost efficiency, and process consistency in preparation for commercial readiness
Provide ongoing oversight of CMO operations, including batch record and testing documentation review, data trending, and deviation/CAPA support consistent with PPQ and late-stage expectations
Coordinate internal and external activities related to patient material and product logistics, ensuring compliant chain-of-identity/chain-of-custody processes critical for pivotal trial operations
Support MSAT planning for development and validation materials, maintaining inventory and coordinating procurement to enable process characterization and PPQ readiness
Execute routine and established laboratory procedures, including assays, cell culture, and analytical tests that feed into process understanding, comparability, and validation efforts
Collect, analyze, and summarize data, monitor for atypical trends, and contribute to data packages used for late-stage decision-making and regulatory submissions
Perform basic statistical data analysis, supporting trending, process capability assessments, and characterization summaries with increasing independence
Other related duties, as assigned

Qualification

Biologics process developmentCell therapy manufacturingTechnology transferProcess optimizationCGMP manufacturingFlow cytometryCell-based bioassaysTeam orientationCommunication skillsProblem-solving skillsOrganizational skills

Required

B.S. with 3 + years or M.S. with 2-3 years' experience within biologics process development, MSAT or manufacturing under cGMP processes or PhD degree
Previous experience and working knowledge of T-cells or immunological cell therapies
Ability to travel up to 10%
Experience with cell therapy manufacturing scale up, technology transfer, and process development and optimization is required
Experience supporting late-stage MSAT activities, including process characterization, PPQ planning/execution, scale-up/scale-out strategies, and continued process verification
Good working knowledge in cGMP manufacturing of biological process and ICH regulations
Strong written and verbal communication skills
Highly organized and efficient
Able to work independently
Strong problem-solving skills
Able to coordinate and prioritize parallel tasks across multiple projects
Strong team orientation and passion for continuous self-development

Preferred

Direct involvement in BLA-enabling MSAT deliverables such as Module 3 process descriptions, validation packages, tech transfer documentation, and inspection readiness strongly preferred
Experience in flow cytometry and cell-based bioassays is a plus
Experience of cold chain logistics is preferred
Experience in the biotech industry or in a startup industrial setting is preferred

Benefits

Competitive benefits
PTO
Stock option plans

Company

Cabaletta Bio

twittertwittertwitter
company-logo
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Funding

Current Stage
Public Company
Total Funding
$310M
Key Investors
5AM Ventures
2025-06-11Post Ipo Equity· $100M
2023-05-17Post Ipo Equity· $87M
2022-12-08Post Ipo Equity· $35M

Leadership Team

leader-logo
Samik Basu
Chief Scientific Officer
linkedin
leader-logo
Steve Gavel
Chief Commercial Officer
linkedin
Company data provided by crunchbase